Endothelial function, arterial stiffness and heart rate variability of patients with cardiovascular diseases hospitalized due to COVID-19

[1]  M. Kar.  Vascular Dysfunction and Its Cardiovascular Consequences During and After COVID-19 Infection: A Narrative Review , 2022, Vascular health and risk management.

[2]  V. Chaturvedi,et al.  Heart rate variability as a marker of cardiovascular dysautonomia in post-COVID-19 syndrome using artificial intelligence , 2022, Indian Pacing and Electrophysiology Journal.

[3]  M. Brodmann,et al.  Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection—A Cross-Sectional Study , 2021, Frontiers in Cardiovascular Medicine.

[4]  M. Maniscalco,et al.  Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation , 2021, Biomedicines.

[5]  M. Brodmann,et al.  Case Report: Changes of Vascular Reactivity and Arterial Stiffness in a Patient With Covid-19 Infection , 2021, Frontiers in Cardiovascular Medicine.

[6]  G. Mancia,et al.  Arterial stiffness and COVID‐19: A bidirectional cause‐effect relationship , 2021, Journal of clinical hypertension.

[7]  Stephen M. Ratchford,et al.  Carotid stiffness, intima–media thickness and aortic augmentation index among adults with SARS‐CoV‐2 , 2021, Experimental physiology.

[8]  E. Benarroch,et al.  Autonomic dysfunction following COVID-19 infection: an early experience , 2021, Clinical Autonomic Research.

[9]  F. Galluccio,et al.  Is the heart rate variability monitoring using the analgesia nociception index a predictor of illness severity and mortality in critically ill patients with COVID-19? A pilot study , 2021, PloS one.

[10]  A. Peltier,et al.  Long-COVID postural tachycardia syndrome: an American Autonomic Society statement , 2021, Clinical Autonomic Research.

[11]  M. Alagesan,et al.  Characterization of cardiac autonomic function in COVID-19 using heart rate variability: a hospital based preliminary observational study , 2021, Journal of basic and clinical physiology and pharmacology.

[12]  S. Zehetmayer,et al.  Arterial stiffness in acute COVID‐19 and potential associations with clinical outcome , 2021, Journal of internal medicine.

[13]  O. Collange,et al.  Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection , 2021, Journal of clinical medicine.

[14]  R. Gómez Huelgas,et al.  Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain , 2020, Hypertension.

[15]  Stephen M. Ratchford,et al.  Vascular alterations among young adults with SARS-CoV-2 , 2020, American journal of physiology. Heart and circulatory physiology.

[16]  J. Scholz,et al.  COVID-19, Renin-Angiotensin System, Angiotensin-Converting Enzyme 2, and Nicotine: What is the Interrelation? , 2020, Arquivos brasileiros de cardiologia.

[17]  L. Boccuto,et al.  Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic , 2020 .

[18]  C. Weber,et al.  Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science , 2020, Cardiovascular research.

[19]  A. Jayarangaiah,et al.  COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response , 2020, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[20]  C. D. Dela Cruz,et al.  Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study , 2020, The Lancet Haematology.

[21]  C. Rochitte,et al.  O Coração e a COVID-19: O que o Cardiologista Precisa Saber , 2020, Arquivos brasileiros de cardiologia.

[22]  J. Ramires,et al.  O Coração e a COVID-19: O que o Cardiologista Precisa Saber , 2020, Arquivos Brasileiros de Cardiologia.

[23]  A. Doroszko,et al.  Profiling the endothelial function using both peripheral artery tonometry (EndoPAT) and Laser Doppler Flowmetry (LD) - Complementary studies or waste of time? , 2020, Microvascular research.

[24]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[25]  Dhanashree S. Kelkar,et al.  The 2019–2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper , 2020, Journal of global infectious diseases.

[26]  D. Diz,et al.  COVID-19, ACE2, and the cardiovascular consequences , 2020, American journal of physiology. Heart and circulatory physiology.

[27]  Mandeep R. Mehra,et al.  COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal , 2020, The Journal of Heart and Lung Transplantation.

[28]  M. Cascella,et al.  Features, Evaluation and Treatment Coronavirus (COVID-19) , 2020 .

[29]  F. Shaffer,et al.  An Overview of Heart Rate Variability Metrics and Norms , 2017, Front. Public Health.

[30]  V. Lemos,et al.  Vascular function in asthmatic children and adolescents , 2017, Respiratory Research.

[31]  N. Olsen,et al.  Evaluation of endothelial function by peripheral arterial tonometry and relation with the nitric oxide pathway. , 2014, Nitric oxide : biology and chemistry.

[32]  L. Ghiadoni,et al.  Endothelial function testing and cardiovascular disease: focus on peripheral arterial tonometry , 2014, Vascular health and risk management.

[33]  Thomas Radtke,et al.  Methodological considerations and practical recommendations for the application of peripheral arterial tonometry in children and adolescents. , 2013, International journal of cardiology.

[34]  F. Dinenno,et al.  Reactive Hyperemia Occurs Via Activation of Inwardly Rectifying Potassium Channels and Na+/K+-ATPase in Humans , 2013, Circulation research.

[35]  L. Brant,et al.  Reproducibility of peripheral arterial tonometry for the assessment of endothelial function in adults , 2013, Journal of hypertension.

[36]  S. Umemura,et al.  Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. , 2012, Journal of the American College of Cardiology.

[37]  M. Moerland,et al.  Evaluation of the EndoPAT as a Tool to Assess Endothelial Function , 2012, International journal of vascular medicine.

[38]  R. Rubinshtein,et al.  Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. , 2010, European heart journal.

[39]  E. Benjamin,et al.  Clinical Correlates and Heritability of Flow-Mediated Dilation in the Community: The Framingham Heart Study , 2004, Circulation.

[40]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .